Last checked at 3 Dec 2018 11:18
3 December 2018
NANOCO GROUP PLC
("Nanoco", the "Group", or the "Company")
Director Declaration
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, makes the following announcement.
In accordance with Listing Rule 9.6.14 the Company announces that Non-Executive Director, Dr Alison Fielding is to take up a non-executive director role with Maven Income and Growth VCT PLC with effect from 1st January 2019.
There are no further disclosures required to be made in respect of Rule 9.6.13 of the Listing Rules.
For further information, please contact:
Nanoco | Tel: +44 (0) 161 603 7900 |
Brian Tenner, Company Secretary | |
Caroline Watson, Investor Relations Manager | Tel: + 44 (0) 7799 897357 |
cwatson@nanocotechnologies.com |
Notes for editors:
About Nanoco Group plc
Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.
Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.
Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.
Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.
- Ends -